Clinical Trials Browser

Phase 1 × Bexarotene × Breast × Clear all

NCT04664829 2025-09-23

The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC

Phase 1 Completed

Triple Negative Breast Neoplasms

NCT03323658 2023-01-10

Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer

Phase 1 Completed

24 enrolled 12 charts

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT00055991 2013-02-05

Bexarotene in Preventing Breast Cancer in Women at Genetic Risk

Phase 1 Completed

Breast Neoplasms